Fx-1006A
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for Fx-1006A, covering 2011-06-23 to 2021-07-29. Get the full timeline:
Most recent: Clinical Trial Update: Safety And Efficacy Evaluation Of Fx-1006A In Subjects With Transthyretin Amyloidosis [Phase 3]